Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Koninklijke Ahold | London | Consumer Non-Cyclicals | Food & Drug Retailing | £27.15B | 17.4x | 5.64 | GBX 3,002.12 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tesco | London | Consumer Non-Cyclicals | Food & Drug Retailing | £26.48B | 17.4x | 0.39 | GBX 406.90 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS | London | Consumer Non-Cyclicals | Food & Drug Retailing | £11.40B | 21.3x | -4.59 | GBX 1,826.55 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carrefour L | London | Consumer Non-Cyclicals | Food & Drug Retailing | £7.73B | 25.6x | -0.44 | GBX 1,096.79 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marks & Spencer | London | Consumer Non-Cyclicals | Food & Drug Retailing | £6.69B | 22.7x | -0.69 | GBX 332 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
J Sainsbury | London | Consumer Non-Cyclicals | Food & Drug Retailing | £6.65B | 16.4x | 0.21 | GBX 295 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
Kesko Oyj | London | Consumer Non-Cyclicals | Food & Drug Retailing | £6.61B | 20.2x | -1.75 | GBX 1,670.73 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Axfood | London | Consumer Non-Cyclicals | Food & Drug Retailing | £5B | 29x | -2.67 | GBX 2,314.59 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colruyt Group | London | Consumer Non-Cyclicals | Food & Drug Retailing | £3.93B | 13.9x | -0.2 | GBX 3,256.62 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sonae SGPS SA | London | Consumer Non-Cyclicals | Food & Drug Retailing | £2.16B | 9.9x | -0.33 | GBX 112.54 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DIA SA | London | Consumer Non-Cyclicals | Food & Drug Retailing | £1.33B | 41x | 0.21 | GBX 2,281.02 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sligro Food Group | London | Consumer Non-Cyclicals | Food & Drug Retailing | £411.64M | 21x | 0.03 | GBX 935.78 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Casino Guichard Perrachon L | London | Consumer Non-Cyclicals | Food & Drug Retailing | £221.55M | -0.4x | -0 | GBX 55.70 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kitwave Group | London | Consumer Non-Cyclicals | Food & Drug Retailing | £194.27M | 12.5x | -0.74 | GBX 232 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Virgin Wines UK | London | Consumer Non-Cyclicals | Food & Drug Retailing | £34.39M | 19.1x | 0.02 | GBX 66.50 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Zambeef | London | Consumer Non-Cyclicals | Food & Drug Retailing | £16.54M | 0.44 | GBX 4 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Roebuck Food | London | Consumer Non-Cyclicals | Food & Drug Retailing | £16.18M | -4.6x | 0.11 | GBX 16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |